Stock Updates

Is this Large Market Cap Stock target price reasonable for Bristol-Myers Squibb Company (NYSE:BMY)?

The company in question is, Bristol-Myers Squibb Company (NYSE:BMY) currently with a stock price of 55.53 (-1.40% today). The market cap for Bristol-Myers Squibb Company is 96047, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Bristol-Myers Squibb Company is 68.85. Currently Bristol-Myers Squibb Company is trading with a P/E of 32.95, and a forward P/E of 18.74. Average volume for Bristol-Myers Squibb Company is 10770.83 and so far today it is 705926.

Performance in the last year for Bristol-Myers Squibb Company has been -2.69%. For EPS growth, Bristol-Myers Squibb Company has seen a growth of -22.30%, and is looking to grow in the next year to 14.34%. More long term stats show that EPS growth has been -12.20% over the last five years and could be 19.59% for the next five years. Bristol-Myers Squibb Company has seen sales growth quarter over quarter at 17.00%, with EPS growth quarter over quarter at 990.60%. The 20-day simple moving average is -16.75%, with the 200-day simple moving average coming to -16.67%.

Since the IPO date for Bristol-Myers Squibb Company on the 6/1/1972, Bristol-Myers Squibb Company has seen performance year to date to be -17.20%. With Bristol-Myers Squibb Company trading at 55.53, the dividend yield is 2.70%, and the EPS is 1.71.

So could Bristol-Myers Squibb Company, be undervalued? Well as said before P/E is 32.95. The PEG is 1.68, P/S is 5.45 and the P/B is at 6.31. The P/cash is 20.65, with P/free cash flow at *TBA.

Bristol-Myers Squibb Company ability to deal with debt shows that the current ratio is 1.6, and the quick ratio is 1.4. This is with long term debt/equity at 0.44, and total debt/equity at 0.45.

In terms of margins, Bristol-Myers Squibb Company has a gross margin of 75.70%, an operating margin of 20.80% and a profit margin of 16.30%.Payout ratio for Bristol-Myers Squibb Company is 87.80%. Return on assets come to 9.00% with return on investment coming to 4.60%.

Insider ownership for Bristol-Myers Squibb Company, is at 0.10% and institutional ownership comes to 74.30%. Outstanding shares are at 1705.38. While shares float is 1504.56. The float short is currently 0.64%, and short ratio is 0.9.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment